Expanding Access to Lifechanging Treatment for Cystic Fibrosis
Providing more people with more options for treatment is another step in our PC government’s work to build a stronger health care system for all Ontarians
Our PC government is expanding coverage for Trikafta, the latest treatment option for cystic fibrosis, to ensure that more children with cystic fibrosis will be able to benefit from this innovative, lifechanging treatment sooner.
The expanded coverage will include all Ontarians aged six and over through its publicly funded drug program. The province is also changing the eligibility criteria to remove the measurement of patients’ lung function in order to further reduce barriers for cystic fibrosis patients to access lifechanging treatments.
“Expanding coverage will ensure that more children with cystic fibrosis will be able to benefit from this innovative, lifechanging treatment sooner,” said Sylvia Jones, MPP for Dufferin-Caledon, Deputy Premier and Minister of Health. “Providing patients with more options for treatment is another step in our government’s work to build a stronger health care system for all Ontarians.”
Following new recommendations by the Canadian Agency for Drugs and Technology in Health (CADTH), Ontario is now the first province to expand access to youth aged 6 to 11.
Providing patients with more options for treatment is another step in our government’s work to build a stronger health care system for all Ontarians.
